Nurosym announced the UK-wide availability of its CE-marked, non-invasive vagus nerve stimulation wearable, backed by AVNT™ technology for those seeking non-drug support for stress, energy and nervous system health.
-- Nurosym has announced a wearable vagus nerve stimulation device, built on Parasym's proprietary AVNT™ technology. Holding CE marking as a Class IIa medical device, Nurosym is permitted across the UK and EU without a prescription - news that will be of keen interest to those looking for non-pharma options to support stress relief, energy and nervous system health.
For more information, visit: https://nurosym.com/pages/how-it-works
As explained by the company, its wearable consists of a small earpiece that clips onto the tragus - in other words, the part of the outer ear situated just in front of the ear canal, where the vagus nerve reaches the surface of the skin. Through this point, the device is built to deliver gentle electrical pulses using AVNT, Parasym's proprietary waveform - engaging the nerve's role in regulating stress, rest and recovery.
Reaching the vagus nerve through the ear is far from a new concept in clinical settings, having been examined across a substantial body of research. According to Nurosym, its device has been developed and refined over the course of more than ten years - supported by over 60 completed clinical studies and more than 100 studies currently underway. Specific research partnerships notably extend to over 150 institutions, including prestigious names such as Harvard and UCLA.
Research from the aforementioned institutions largely points to measurable physiological changes. Clinical studies found that vagus nerve activity increased by an average of 61%, while heart rate variability increased separately by an average of 18%. A reduction in fatigue was also reported as a distinct outcome - positioning Nurosym as a legitimate means of supporting the nervous system alongside existing medical care.
Moreover, the device is described as conducive to a straightforward daily routine. Most users wear the device for around 30 minutes, once or twice a day, during ordinary activities such as working, reading or watching television, says the company.
In addition, no clinic visit or prescription is required - allowing users to easily fit nervous system support into their existing schedules. Even more crucially, the CE-marked medical device demonstrably sits within a category subject to defined safety and performance standards under EU regulation.
Their spokesperson adds: “When used correctly, Nurosym may boost parasympathetic activity by over 61% in just five minutes and deliver 2-4x greater parasympathetic activation than breathwork or meditation. Monitor your HRV with a smart device like Apple watch to track progress.”
Interested parties can find further details about the technology behind Nurosym along with its research base at: https://nurosym.com/
Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as medical claims or guaranteed individual outcomes. Nurosym is a CE-marked medical device in Europe.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nurosym by Parasym
Address: 18 Saint Cross Street 4th Floor, London, England EC1N 8UN, United Kingdom
Website: https://nurosym.com/
Source: PressCable
Release ID: 89205839
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.
